105 related articles for article (PubMed ID: 11044472)
21. Sib understanding of genetics and attitudes toward carrier testing for X-linked severe combined immunodeficiency.
Fanos JH; Davis J; Puck JM
Am J Med Genet; 2001 Jan; 98(1):46-56. PubMed ID: 11426455
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy for severe combined immunodeficiency disease.
Handgretinger R; Koscielniak E; Niethammer D
N Engl J Med; 2002 Aug; 347(8):613-4; author reply 613-4. PubMed ID: 12192024
[No Abstract] [Full Text] [Related]
23. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID.
Minegishi Y; Ishii N; Tsuchida M; Okawa H; Sugamura K; Yata J
Bone Marrow Transplant; 1995 Dec; 16(6):801-6. PubMed ID: 8750273
[TBL] [Abstract][Full Text] [Related]
24. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.
Flake AW; Roncarolo MG; Puck JM; Almeida-Porada G; Evans MI; Johnson MP; Abella EM; Harrison DD; Zanjani ED
N Engl J Med; 1996 Dec; 335(24):1806-10. PubMed ID: 8943162
[No Abstract] [Full Text] [Related]
25. Canine X-linked severe combined immunodeficiency. A model for investigating the requirement for the common gamma chain (gamma c) in human lymphocyte development and function.
Felsburg PJ; Somberg RL; Hartnett BJ; Henthorn PS; Carding SR
Immunol Res; 1998; 17(1-2):63-73. PubMed ID: 9479568
[TBL] [Abstract][Full Text] [Related]
26. [Gene therapy and clinical trials].
Tazawa R; Pradono P; Hagiwara K; Nukiwa T
Nihon Rinsho; 2002 May; 60 Suppl 5():625-9. PubMed ID: 12101750
[No Abstract] [Full Text] [Related]
27. Bone marrow transplantation in severe combined immunodeficiency from a sibling who had received a paternal bone marrow transplant.
Stiehm ER; Roberts RL; Hanley-Lopez J; Wakim ME; Pallavicini MG; Cowan MJ; Ettenger RB; Feig SA
N Engl J Med; 1996 Dec; 335(24):1811-4. PubMed ID: 8943163
[No Abstract] [Full Text] [Related]
28. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
29. X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.
Leonard WJ
Mol Med Today; 2000 Oct; 6(10):403-7. PubMed ID: 11006530
[TBL] [Abstract][Full Text] [Related]
30. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
31. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
[TBL] [Abstract][Full Text] [Related]
32. Outpatient bone marrow transplantation for severe combined immunodeficiency.
Sorensen RU; Strandjord SE; Coccia PF
Lancet; 1993 Jan; 341(8836):52. PubMed ID: 8093296
[No Abstract] [Full Text] [Related]
33. Acute monocytic leukemia in a dog with X-linked severe combined immunodeficiency.
Felsburg PJ; Somberg RL; Krakowka GS
Clin Diagn Lab Immunol; 1994 Jul; 1(4):379-84. PubMed ID: 8556472
[TBL] [Abstract][Full Text] [Related]
34. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
35. [Gene therapy for severe combined immunodeficiency].
Petersen LB; Jensen TG
Ugeskr Laeger; 2010 Jun; 172(23):1756-8. PubMed ID: 20534204
[TBL] [Abstract][Full Text] [Related]
36. US panel advises resumption of gene trials.
Fox JL
Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
[No Abstract] [Full Text] [Related]
37. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
38. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).
Leonard WJ; Noguchi M; Russell SM
Adv Exp Med Biol; 1994; 365():225-32. PubMed ID: 7887307
[No Abstract] [Full Text] [Related]
39. [Gene therapy of severe combined immunodeficiencies].
Cavazzana-Calvo M; Hacein-Bey S; de Saint-Basile G; Le Deist F; Fischer A
Transfus Clin Biol; 2000 Jun; 7(3):259-60. PubMed ID: 10919216
[No Abstract] [Full Text] [Related]
40. T-cell-depleted maternal bone marrow transplantation for siblings with X-linked severe combined immunodeficiency.
Himelstein BP; Puck J; August C; Pierson G; Bunin N
J Pediatr; 1993 Feb; 122(2):289-91. PubMed ID: 8429448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
